BMC Cancer

official impact factor 3.15
Search for
Advanced search
BMC Cancer
Tools
Share this article
Open Access Highly Access Email this article to a friend

Front-line Bevacizumab in combination with Oxaliplatin, Leucovorin and 5-Fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study

Christos Emmanouilides, Georgia Sfakiotaki, Nikolaos Androulakis, Kostas Kalbakis, Charalambos Christophylakis, Antonia Kalykaki, Lambros Vamvakas, Athanasios Kotsakis, Sofia Agelaki, Eleni Diamandidou, Nikolaos Touroutoglou, Adam Chatzidakis, Vassilis Georgoulias, Dimitris Mavroudis and John Souglakos*

BMC Cancer 2007, 7:91 doi:10.1186/1471-2407-7-91

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.